Stem Cell-Based Tissue-Engineered Laryngeal Replacement (2017)
Attributed to:
RegenVOX: phase I/II clinical trial of stem cell based tissue engineered laryngeal implants
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.5966/sctm.2016-0130
PubMed Identifier: 27612519
Publication URI: http://europepmc.org/abstract/MED/27612519
Type: Journal Article/Review
Parent Publication: Stem Cells Translational Medicine
Issue: 2
ISSN: 2157-6564